Vandetanib in Preventing Head and Neck Cancer in Patients With Precancerous Head and Neck Lesions

Summary

This randomized phase II trial studies how well vandetanib works in preventing head and neck cancer in patients with precancerous head and neck lesions. Chemoprevention is the use of certain drugs to keep cancer from forming. The use of vandetanib may keep cancer from forming in patients with premalignant lesions

Timeline

Start

2012-01

Primary completion

2019-01-01

Completion

2019-06-01

Drugs

Indications